Next-generation Diagnosticsfor a Better Life

Addressing the Point-of-Care

We bring widely accessible, next generation screening tools to the market. Our flagship device, the Pandora CDx point-of-care system resolves the two systemic issues with modern diagnostics: geographic inaccessibility and cost prohibition.

Saving Lives with Early Detection

The Pandora CDx™ Point-of-Care System

The Pandora CDx™, developed by POC Medical Systems, is a technology platform designed for rapid, accurate, and portable disease screening at the point-of-care. This unique “lab-in-a-box” is a miniaturized version of the laboratory process contained within a microfluidic CD. At a minimal cost significantly less than a mammogram, with a test-to-result time of about 30 minutes, high sensitivity and specificity, and requiring only a few drops of blood, our first product to market, MammoAlert™, is a true breast cancer pre-screening tool. MammoAlert™ is breaking barriers and is available to both women in rural and urban areas across the globe.

The Growing Cancer Pandemic

Each year there are over 14 million new cases of cancer and more than 8 million cancer related deaths even though nearly 70% of cancer is curable if detected early. Breast cancer is the leading cause of cancer in women worldwide with 23% of all cancer cases due to breast cancer and more than 1.7 million new cases of cancer diagnosed globally each year. The annual combined death toll from breast cancer is over half a million. According to the WHO, only 60 million of the world’s women have been screened, 25 million of whom are in the United States. In countries like China and India with vast unscreened populations, the reality may be closer to over 16 million cases of breast cancer which could result in 4.5 million global deaths unless detected early.

Problems with the Current Solution

While mammography is considered the gold standard in breast cancer screening, it is problematic due to its requirement for trained personnel, geographic inaccessibility, long test-to-result time, and high false positive rate. Mammography, like most modern diagnostics, is simply not accessible to most of the women in the world that require regular breast cancer screening. Of the 1.6 billion women over 40 worldwide, less than 4% are regularly screened for breast cancer using mammography.

The Breast Cancer Problem in India

India is at the forefront of developing some of the world’s top doctors and its private hospital system is world-renowned. Why are its citizens so sick? The incidence of breast cancer in India is on the rise. Breast cancer has now eclipsed cervical cancer as the leading cause of cancer for all women in India. While the reason more women are developing breast cancer is the subject of debate, it is clear India’s healthcare system is not adequately prepared to screen for breast cancer or treat it.

The Breast Cancer Problem in China

China does not have a formal screening program in place for breast cancer - the leading cause of cancer related deaths. Of the 350 million over the age of 40 in China, only 7.5 million are screened annually. That’s a screening rate of just above 2% for a disease that will afflict 1-in-8 Chinese women.While mammography is available in all of China’s cities, Chinese farmers living in rural parts of the country are forced to travel into cities for the procedure. This is both cost and time prohibitive to most women who have neither the time nor the money to travel to the nearest city for an annual screening. The unfortunate reality is many in China that develop breast cancer come to know of their cancer only after they discover a lump and the cancer has metastasized. At that point treatment options are not only expensive, but patient outlook is bleak.